Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
11.2M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
125K
-
Shares change
-
+23.4K
-
Total reported value, excl. options
-
$272K
-
Value change
-
+$50.9K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$2.18
Significant Holders of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) as of Q4 2024
13 filings reported holding BCDA - BioCardia, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 125K shares
of 11.2M outstanding shares and own 1.12% of the company stock.
Largest 10 shareholders include SUSQUEHANNA INTERNATIONAL GROUP, LLP (43.8K shares), GEODE CAPITAL MANAGEMENT, LLC (31K shares), CM Management, LLC (25K shares), VANGUARD GROUP INC (12.9K shares), UBS Group AG (4.75K shares), MORGAN STANLEY (4.02K shares), Pingora Partners LLC (1.04K shares), JPMORGAN CHASE & CO (899 shares), Tower Research Capital LLC (TRC) (535 shares), and BANK OF AMERICA CORP /DE/ (413 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.